Metropolitan Life Insurance CO Cytom X Therapeutics, Inc. Transaction History

Metropolitan Life Insurance CO

  • $281 Million
  • Q3 2024

Shares

47 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 11, 2022
SELL
$1.53 - $2.89 $7,203 - $13,606
-4,708 Closed
0 $0
Q1 2022

Jun 20, 2023
BUY
$2.67 - $4.68 $12,570 - $22,033
4,708 New
4,708 $12,000
Q1 2022

Mar 30, 2023
SELL
$2.67 - $4.68 $17,979 - $31,515
-6,734 Reduced 58.85%
4,708 $12,000
Q1 2022

May 12, 2022
SELL
$2.67 - $4.68 $17,979 - $31,515
-6,734 Reduced 58.85%
4,708 $13,000
Q4 2021

Jun 21, 2023
BUY
$3.87 - $7.39 $44,280 - $84,556
11,442 New
11,442 $49,000
Q4 2021

Mar 30, 2023
BUY
$3.87 - $7.39 $18,560 - $35,442
4,796 Added 72.16%
11,442 $49,000
Q4 2021

Feb 15, 2022
BUY
$3.87 - $7.39 $18,560 - $35,442
4,796 Added 72.16%
11,442 $50,000
Q3 2021

Jun 21, 2023
BUY
$4.32 - $6.43 $28,710 - $42,733
6,646 New
6,646 $33,000
Q3 2021

Mar 30, 2023
SELL
$4.32 - $6.43 $53,040 - $78,947
-12,278 Reduced 64.88%
6,646 $33,000
Q3 2021

Nov 15, 2021
SELL
$4.32 - $6.43 $53,040 - $78,947
-12,278 Reduced 64.88%
6,646 $34,000
Q2 2021

Jun 21, 2023
BUY
$6.33 - $9.91 $119,788 - $187,536
18,924 New
18,924 $119,000
Q2 2021

Mar 30, 2023
BUY
$6.33 - $9.91 $16,261 - $25,458
2,569 Added 15.71%
18,924 $119,000
Q2 2021

Aug 16, 2021
BUY
$6.33 - $9.91 $119,687 - $187,378
18,908 Added 118175.0%
18,924 $120,000
Q1 2021

Jun 26, 2023
BUY
$6.6 - $9.0 $107,943 - $147,195
16,355 New
16,355 $126 Million
Q1 2021

Mar 30, 2023
BUY
$6.6 - $9.0 $78,573 - $107,145
11,905 Added 267.53%
16,355 $126,000
Q1 2021

May 14, 2021
SELL
$6.6 - $9.0 $29,264 - $39,906
-4,434 Reduced 99.64%
16 $126,000
Q4 2020

Jun 22, 2023
BUY
$6.47 - $7.9 $28,791 - $35,155
4,450 New
4,450 $29,000
Q4 2020

Mar 30, 2023
SELL
$6.47 - $7.9 $64,635 - $78,921
-9,990 Reduced 69.18%
4,450 $29,000
Q4 2020

Feb 16, 2021
SELL
$6.47 - $7.9 $64,635 - $78,921
-9,990 Reduced 69.18%
4,450 $29,000
Q3 2020

Jun 26, 2023
BUY
$6.55 - $8.83 $94,582 - $127,505
14,440 New
14,440 $96,000
Q3 2020

Mar 30, 2023
SELL
$6.55 - $8.83 $1,270 - $1,713
-194 Reduced 1.33%
14,440 $96,000
Q3 2020

Nov 13, 2020
SELL
$6.55 - $8.83 $1,270 - $1,713
-194 Reduced 1.33%
14,440 $96,000
Q2 2020

Jun 26, 2023
BUY
$7.4 - $14.64 $108,291 - $214,241
14,634 New
14,634 $121,000
Q2 2020

Mar 30, 2023
BUY
$7.4 - $14.64 $43,349 - $85,761
5,858 Added 66.75%
14,634 $121,000
Q2 2020

Aug 14, 2020
BUY
$7.4 - $14.64 $43,349 - $85,761
5,858 Added 66.75%
14,634 $122,000
Q1 2020

Jul 12, 2023
BUY
$3.61 - $8.6 $31,681 - $75,473
8,776 New
8,776 $67,000
Q1 2020

Mar 30, 2023
SELL
$3.61 - $8.6 $11,533 - $27,477
-3,195 Reduced 26.69%
8,776 $67,000
Q1 2020

May 15, 2020
SELL
$3.61 - $8.6 $11,533 - $27,477
-3,195 Reduced 26.69%
8,776 $67,000
Q4 2019

Jul 12, 2023
BUY
$5.17 - $8.91 $61,890 - $106,661
11,971 New
11,971 $99,000
Q4 2019

Mar 30, 2023
SELL
$5.17 - $8.91 $34,695 - $59,795
-6,711 Reduced 35.92%
11,971 $99,000
Q4 2019

Feb 14, 2020
SELL
$5.17 - $8.91 $34,695 - $59,795
-6,711 Reduced 35.92%
11,971 $99,000
Q3 2019

Jul 12, 2023
BUY
$7.38 - $12.25 $137,873 - $228,854
18,682 New
18,682 $137,000
Q3 2019

Mar 30, 2023
BUY
$7.38 - $12.25 $49,246 - $81,744
6,673 Added 55.57%
18,682 $137,000
Q3 2019

Nov 14, 2019
BUY
$7.38 - $12.25 $49,246 - $81,744
6,673 Added 55.57%
18,682 $138,000
Q2 2019

Jul 12, 2023
BUY
$9.35 - $11.41 $127,010 - $154,993
13,584 New
13,584 $152,000
Q1 2019

Jul 13, 2023
BUY
$9.5 - $19.16 $114,085 - $230,092
12,009 New
12,009 $129,000
Q1 2019

Mar 30, 2023
BUY
$9.5 - $19.16 $114,085 - $230,092
12,009 New
12,009 $129,000
Q1 2019

May 16, 2019
SELL
$9.5 - $19.16 $355,053 - $716,085
-37,374 Reduced 75.68%
12,009 $129,000
Q1 2019

May 15, 2019
BUY
$9.5 - $19.16 $341,088 - $687,920
35,904 Added 266.37%
49,383 $2.47 Million
Q4 2018

Jul 13, 2023
BUY
$12.69 - $18.61 $171,048 - $250,844
13,479 New
13,479 $203,000
Q4 2018

Feb 14, 2019
BUY
$12.69 - $18.61 $135,148 - $198,196
10,650 Added 376.46%
13,479 $204,000
Q3 2018

Jul 13, 2023
BUY
$18.04 - $26.41 $233,022 - $341,137
12,917 New
12,917 $239 Million
Q3 2018

Nov 14, 2018
SELL
$18.04 - $26.41 $181,987 - $266,424
-10,088 Reduced 78.1%
2,829 $52,000
Q2 2018

Aug 15, 2018
BUY
$21.38 - $29.68 $73,376 - $101,861
3,432 Added 36.18%
12,917 $0
Q1 2018

May 15, 2018
BUY
$21.76 - $34.22 $4,069 - $6,399
187 Added 2.01%
9,485 $0
Q4 2017

Feb 15, 2018
SELL
$19.0 - $23.09 $149,682 - $181,903
-7,878 Reduced 45.87%
9,298 $196,000
Q2 2017

Aug 14, 2017
BUY
N/A
17,176
17,176 $266,000

Others Institutions Holding CTMX

# of Institutions
72
Shares Held
49.4M
Call Options Held
112K
Put Options Held
8.3K
View Full List

About CytomX Therapeutics, Inc.

CTMX Quotes by TradingView
  • Ticker CTMX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 65,950,200
  • Market Cap $55.4M
  • Description
  • CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody therapeutics based on its Probody technology platform for the treatment of cancer. The company's product candidates include CX-2009, an antibody drug conjugates (ADC) against CD166, which is in Phase II clinical...
More about CTMX
Track This Portfolio

Track Metropolitan Life Insurance CO Portfolio

Follow Metropolitan Life Insurance CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email